Skip to content

Sanara MedTech Inc. SMTI Conversion Of Note Receivable Into Equity Method Investment

Conversion Of Note Receivable Into Equity Method Investment at other companies

Blend Labs logo
Blend LabsBLND
$2.42M
Alarm.com Holdings logo
Alarm.com HoldingsALRM
$1.8M
Blend Labs logo
Blend LabsBLND
-$206.25K
Dine Brands Global logo
Dine Brands GlobalDIN
$700K-30.0%
Verb Technology Company, Inc. logo
Verb Technology Company, Inc.TONX
$2.6M
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
$1.53M

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept SMTI:ConversionOfNoteReceivableIntoEquityMethodInvestment.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s conversion of note receivable into equity method investment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s conversion of note receivable into equity method investment?
Sanara MedTech Inc. (SMTI) reported conversion of note receivable into equity method investment of $1.1M in Q1 2025.
What does conversion of note receivable into equity method investment mean?
Reflects the non-cash conversion of a debt instrument (note receivable) into an equity interest in another entity. This indicates a strategic shift from a creditor position to an ownership or partnership stake in an investee.